全文获取类型
收费全文 | 6560篇 |
免费 | 449篇 |
国内免费 | 12篇 |
学科分类
医药卫生 | 7021篇 |
出版年
2024年 | 9篇 |
2023年 | 75篇 |
2022年 | 118篇 |
2021年 | 292篇 |
2020年 | 155篇 |
2019年 | 231篇 |
2018年 | 242篇 |
2017年 | 196篇 |
2016年 | 204篇 |
2015年 | 237篇 |
2014年 | 306篇 |
2013年 | 451篇 |
2012年 | 620篇 |
2011年 | 574篇 |
2010年 | 271篇 |
2009年 | 262篇 |
2008年 | 437篇 |
2007年 | 426篇 |
2006年 | 397篇 |
2005年 | 390篇 |
2004年 | 287篇 |
2003年 | 216篇 |
2002年 | 219篇 |
2001年 | 50篇 |
2000年 | 29篇 |
1999年 | 37篇 |
1998年 | 49篇 |
1997年 | 17篇 |
1996年 | 18篇 |
1995年 | 12篇 |
1994年 | 11篇 |
1993年 | 20篇 |
1992年 | 20篇 |
1991年 | 13篇 |
1990年 | 16篇 |
1989年 | 10篇 |
1988年 | 14篇 |
1987年 | 28篇 |
1986年 | 10篇 |
1985年 | 11篇 |
1984年 | 12篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1973年 | 3篇 |
1967年 | 2篇 |
1966年 | 2篇 |
排序方式: 共有7021条查询结果,搜索用时 15 毫秒
1.
2.
Setting goals to maintain hope. 总被引:3,自引:0,他引:3
3.
Diarrhetic shellfish poisoning (DSP) is a serious and globally widespread phytoplankton-related seafood illness. Although DSP is rarely life-threatening, it causes incapacitating diarrhea and vomiting with no known medical treatments. In addition, phytoplankton producing DSP toxins have been identified in temperate coastal waters worldwide, and their numbers may be increasing as a result of coastal eutrophication. The toxic effects of the major DSP toxins, okadaic acid and dinophysistoxin-1 (35-methylokadaic acid), appear to originate from their inhibitory activity against a family of structurally related serine/threonine protein phosphatases (PSPases). In particular, the inhibition of essential PSPases (e.g. PP1 and PP2A) has catastrophic consequences in most eukaryotic cells. Exploiting the potent inhibitory property of the DSP toxins, we have developed an enzyme-based assay (PP2A assay) capable of detecting both okadaic acid and dinophysis- toxin-1 in nanogram amounts. The assay employs purified PP2A, which has an extremely high affinity for both DSP toxins. This provides the PP2A assay with a level of sensitivity comparable to, or surpassing, that of most monoclonal antibody probes. To evaluate the PP2A assay as a means of detecting contaminated shellfish, a series of spike recovery experiments was conducted. The findings from these studies suggest that the PP2A assay has the potential for development into a rapid and relatively simple method for detecting PSPase inhibitors in crude extracts produced from shellfish. 相似文献
4.
5.
6.
7.
8.
Susan E Krown Ping Li Jamie H Von Roenn Josephine Paredes Jie Huang Marcia A Testa 《Journal of interferon & cytokine research》2002,22(3):295-303
We wished to evaluate the efficacy and safety of a low and an intermediate daily dose of interferon-alpha2b (IFN-alpha2b) with didanosine in patients with acquired immunodeficiency syndrome (AIDS)-associated Kaposi's sarcoma (KS). HIV-seropositive subjects with biopsy-confirmed cutaneous KS were randomized to receive either a low (1 million IU) or an intermediate (10 million IU) dose of IFN-alpha2b once daily with twice daily doses of didanosine. Treatment assignment was stratified by CD4 count. Response, toxicity, changes in CD4 counts, and survival were evaluated. Sixty-eight eligible subjects were accrued, 35 to low-dose and 33 to intermediate-dose IFN-alpha2b. The response rate was 40% in the low-dose group (95% CI, 24-58) and 55% in the intermediate-dose group (95% CI, 36-72) (p = 0.338). The median response duration was approximately 110 weeks in both groups. Intermediate-dose IFN induced grade 3/4 neutropenia more often (21% vs. 3%, p = 0.048) and grade 3/4 toxicity faster (p = 0.0231) and necessitated treatment discontinuation earlier for drug-related toxicities (p = 0.0416) than low-dose IFN. There were no significant differences in survival between the treatment groups. Baseline CD4 count was the only significant factor predicting response. Once-daily low-dose and intermediate-dose IFN-alpha2b induced similar response rates, which were achieved without optimal antiretroviral therapy. The slightly higher response rate in the intermediate-dose group was offset by its significantly poorer tolerance. These findings justify the use of lower, well-tolerated IFN doses for treatment of KS with currently used antiretroviral regimens. 相似文献
9.